This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
While part of the story is an increased ability to diagnose cancers early, thanks to...
While part of the story is an increased ability to diagnose cancers early, thanks to...
In this HotCopper Capital Compass interview, Prescient Therapeutics (ASX:PTX) CEO James McDonnell discusses the company’s progress with PTX-100, a...

This investor centre was built by Reach Markets
©2026 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.